- The trend backdrop is active with a 11-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
- Activity pressure is constructive, supporting the smart-money activity read.
BANKA
NSI
Week ended 07 Aug 2026
Weekly Investor Report
Banka BioLoo Limited · Industrials · Pollution & Treatment Controls
Latest close
86.31 INR
0.3%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is 17.2% above the Trend Line and sits at 79.7% of its 52-week range. The latest completed week returned 0.3%, after a -6.2% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 53/100. Near-term considerations: volume confirmation is below normal.
Setup score
54
out of 100
Latest Close
86.31 INR
7 Aug 2026
1W Return
0.3%
latest completed week
4W Return
-6.2%
short-term follow-through
12W Return
3.4%
quarterly tape
Trend Breadth
48.1%
25 of 52 weeks active
Volume Ratio
0.8x
vs 13-week average
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 38.10% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
0.3%
Latest completed week; four-week move -6.2%.
Indicator stack
65/48
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 38.10%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
53/100
5 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 17.2% above the Trend Line and sits at 79.7% of its 52-week range. The latest completed week returned 0.3%, after a -6.2% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.8x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.9212-week average 0.71
12-week confirmation
Trend active11/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.92Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -6.2% over four weeks, 3.4% over 12 weeks, and -0.3% over one year. The current trend has remained active for 11 consecutive weeks.
Performance by holding period
Active trend streak11 weeks
Active weeks in one year25
Trend breadth48.1%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.24Latest activity-pressure read.
Pressure change-77.4%Four-week change in activity pressure.
Leadership13.10Latest relative-leadership reading.
RS change-44.0%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 88%
Model confidence 82%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength69/100Blend of value, momentum, and quality. Underlying universe rank 32; rank 1 is best.
Value57/100Relative valuation strength. Underlying universe rank 44; rank 1 is best.
Quality56/100Profitability and accounting quality. Underlying universe rank 45; rank 1 is best.
Momentum59/100Medium-term price momentum. Underlying universe rank 42; rank 1 is best.
Growth57/100Revenue and earnings growth. Underlying universe rank 44; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework7/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 249.8x Price divided by trailing earnings.
- Price / sales
- 1.6x Market value relative to trailing revenue.
- EV / EBITDA
- 20.6x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- -3.9% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 75.5% Gross profit retained from each unit of revenue.
- Operating margin
- 4.1% Operating profit retained from revenue.
- Free-cash-flow margin
- -8.7% Free cash flow generated from revenue.
- Return on invested capital
- 2.5% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 5.4% Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 7/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- -0.1% Net share repurchases relative to market value.
- Shareholder yield
- -0.1% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 4.9x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment53/100
Weighted news tone is neutral across 5 relevant articles.
1 positive · 4 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-11.8%Distance below the 52-week high.
13-week volatility3.3%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher13 of 2613 weeks finished lower.
Best week+39.8%Week of 10 Apr.
Worst week-10.9%Week of 13 Mar.
Latest week+0.3%Week of 7 Aug.
Shape of recent returns
Strong gains6
Modest gains7
Flat weeks0
Modest losses7
Sharp losses6
Recent vol3.3%13-week weekly-return volatility.
Base vol7.7%52-week weekly-return volatility.
Up/down split24/28Count of positive and negative weeks in the 52-week window.
Average skew5.2% / -4.0%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIN Industrials
4-week rank- / 100
Group average0.8%
Trend breadth62.0%
Trend62.0%active weekly trend signals
MD43.0%positive activity pressure
RS60.0%positive relative leadership
Four-week leaders
IndustryIN Pollution & Treatment Controls
4-week rank1 / 2
Group average-13.4%
Trend breadth100.0%
Trend100.0%active weekly trend signals
MD100.0%positive activity pressure
RS50.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape57/100
Trend, activity pressure, participation, and risk combine to a 57/100 tape read.
Indicator analysis88/100Latest 12-week confirmation: trend 11/12, activity pressure 12/12, relative leadership 12/12.
Activity pressure 0.92; No reversal markers Next-Week ExpectancyNegative 38.10%Next-week expectancy is negative with a 38.10% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors60/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 75 SVQF7/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 1471.5 of 1576 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment53/100Weighted news tone is neutral across 5 relevant articles.
Banka Bioloo Ltd Valuation Shifts: From Attractive to Fair Amidst Mixed Market Returns Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 86.31 INR | 0.3% | 73.66 INR | 88.85 INR | 0.24 | 13.10 | 11.2K | On |
| 31 Jul 2026 | 86.01 INR | -5.2% | 72.89 INR | 88.74 INR | 0.64 | 13.55 | 9.2K | On |
| 24 Jul 2026 | 90.77 INR | -2.8% | 72.28 INR | 88.64 INR | 0.93 | 23.07 | 6.5K | On |
| 17 Jul 2026 | 93.40 INR | 1.5% | 71.42 INR | 88.50 INR | 1.07 | 23.78 | 7.5K | On |
| 10 Jul 2026 | 92.02 INR | -0.2% | 70.54 INR | 88.33 INR | 1.07 | 23.41 | 31.3K | On |
| 3 Jul 2026 | 92.22 INR | 2.4% | 69.67 INR | 88.18 INR | 0.99 | 24.14 | 8.8K | On |
| 26 Jun 2026 | 90.09 INR | 1.2% | 68.94 INR | 88.03 INR | 0.97 | 23.10 | 0 | On |
| 19 Jun 2026 | 89.00 INR | -1.8% | 68.43 INR | 87.89 INR | 1.03 | 22.56 | 6.4K | On |
| 12 Jun 2026 | 90.60 INR | -2.1% | 67.96 INR | 87.76 INR | 1.05 | 27.59 | 2.1K | On |
| 5 Jun 2026 | 92.50 INR | 4.2% | 67.84 INR | 87.63 INR | 1.07 | 32.56 | 2.6K | On |
| 29 May 2026 | 88.75 INR | 8.2% | 67.70 INR | 87.49 INR | 1.10 | 27.38 | 42.7K | On |
| 22 May 2026 | 82.00 INR | -1.8% | 67.65 INR | 87.38 INR | 1.17 | 17.65 | 25.1K | Off |
| 15 May 2026 | 83.50 INR | -0.8% | 67.83 INR | 87.32 INR | 1.16 | 20.76 | 19.8K | Off |
| 8 May 2026 | 84.15 INR | 2.4% | 67.97 INR | 87.25 INR | 1.25 | 19.62 | 36.6K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.